year
hivaid
wreak
havoc
world
absenc
effect
vaccin
hiv
develop
new
antihiv
agent
urgent
need
previous
identifi
antivir
activ
scorpionvenompeptidederiv
three
rna
virus
measl
virus
sarscov
investig
panel
scorpion
venom
peptid
deriv
design
chosen
assess
antihiv
activ
new
scorpion
venom
peptid
deriv
identifi
potent
peptid
screen
assay
ec
valu
mgml
mm
show
low
cytotox
host
cell
select
index
si
could
inhibit
member
standard
refer
panel
subtyp
b
pseudotyp
viru
pv
pv
strain
furthermor
also
inhibit
replicationcompet
strain
subtyp
b
viru
bind
assay
pv
octet
red
system
suggest
activ
correl
direct
interact
envelop
result
demonstr
peptid
could
inhibit
direct
interact
viral
particl
may
becom
promis
candid
compound
develop
microbicid
nearli
million
peopl
live
human
immunodefici
viru
hiv
end
globe
half
women
unfortun
still
effect
vaccin
countermeasur
elimin
hiv
transmiss
merck
step
thai
hiv
vaccin
trial
confirm
still
long
way
go
develop
prophylact
hiv
vaccin
meanwhil
hiv
viru
spread
fast
hivaid
pandem
still
stand
seriou
public
health
problem
worldwid
current
situat
clearli
indic
necess
develop
new
antihiv
agent
use
prevent
hivaid
dissemin
initi
infect
cell
receptor
either
two
chemokin
coreceptor
suggest
major
coreceptor
involv
sexual
transmiss
microbicid
test
inde
inhibit
infect
insuffici
inhibit
extent
dendrim
virucid
activ
strain
viru
strain
effect
safeti
broad
spectrum
import
antihiv
microbicid
chemokin
analogu
pscrant
strong
inhibit
activ
hiv
strain
might
induc
local
inflamm
sulfon
polym
safe
provid
efficaci
protect
sexual
hiv
transmiss
polyanioun
suggest
potenti
microbicid
unfortun
recent
phase
iii
trial
cellulos
sulfat
termin
increas
rate
hiv
infect
women
use
placebo
therefor
sourc
antivir
reagent
prevent
transmiss
need
effici
protect
bodi
hiv
infect
natur
antimicrobi
peptid
amp
wide
express
rapidli
induc
epitheli
surfac
repel
invas
divers
infecti
agent
includ
bacteria
virus
fungi
parasit
far
amp
differ
origin
identifi
predict
amp
maintain
certain
common
featur
small
amino
acid
contain
posit
charg
amphipath
structur
scorpion
venom
cocktail
peptid
protein
divers
bioactiv
repres
tremend
potenti
use
drug
design
develop
amp
scorpion
venom
hadrurin
scorpin
opistoporin
parabutoporin
isct
mucroporin
paid
attent
due
biolog
activ
molecul
activ
viral
pathogen
junin
viru
herp
simplex
viru
adenoviru
rotaviru
vaccinia
viru
hcv
measl
viru
report
previous
mucroporin
clone
venom
scorpion
lycha
mucronatu
optim
deriv
show
antimicrobi
activ
bacteria
measl
viru
anoth
scorpion
peptid
clone
venom
mesobuthu
martensii
karsch
also
show
strong
antimicrobi
activ
bacteria
develop
peptid
new
peptid
name
design
substitut
glycin
alanin
serin
lysin
arginin
enhanc
net
posit
charg
ahelix
structur
studi
five
scorpion
venom
peptid
deriv
screen
activ
result
show
three
exhibit
potent
activ
show
highest
level
activ
specul
might
potenti
lead
peptid
test
antivir
effect
use
standard
refer
panel
subtyp
b
pseudotyp
viru
pv
replicationcompet
strain
viru
bind
assay
pv
perform
explor
relat
antivir
mechan
octet
red
system
molecular
design
synthesi
purif
character
peptid
fikriarllrkif
design
base
peptid
sequenc
figaiarllskif
enhanc
net
posit
charg
hydrophil
side
peptid
contain
five
posit
charg
carri
two
posit
charg
tabl
glycin
alanin
serin
residu
replac
lysin
arginin
secondari
structur
predict
phd
method
websit
http
npsapbilibcpfrcgibinnpsaautomat
pl
page
npsanpsasecconshtml
suggest
higher
ahelix
percentag
respect
inform
mucroporin
describ
previou
studi
five
peptid
success
synthes
abim
am
synthes
fmoc
solidphas
peptid
synthesi
puriti
five
peptid
show
reliabl
qualiti
molecul
weight
measur
mass
spectrometri
ms
complet
match
calcul
molecul
weight
peptid
identifi
effect
scorpion
venom
peptid
pv
screen
assay
assess
antihiv
activ
scorpion
venom
peptid
pseudotyp
virusbas
assay
tzmbl
system
adopt
screen
effect
differ
peptid
result
show
could
significantli
decreas
infect
clade
b
pseudotyp
viru
compar
mucroporin
bsa
nopeptid
viru
mock
control
peptid
show
highest
level
activ
almost
complet
inhibit
viral
infect
fig
gave
us
hint
peptid
potenti
develop
antihiv
agent
therefor
peptid
chosen
studi
clarifi
antihiv
effect
chosen
neg
control
studi
show
antibacteri
antivir
activ
previou
research
similar
number
amino
acid
peptid
act
sensit
rapidli
pv
confirm
whether
activ
depend
concentr
sever
concentr
activ
measur
pseudotyp
virusbas
assay
tzmbl
detect
system
shown
fig
antiviralact
pv
dosedepend
manner
inhibit
achiev
concentr
mgml
ec
valu
calcul
mgml
inhibit
could
achiev
concentr
rose
mgml
determin
effect
time
need
act
pv
mgml
peptid
incub
tcid
pv
min
min
min
min
min
respect
shown
fig
min
min
longer
time
treatment
higher
inhibit
achiev
signific
differ
observ
min
treatment
group
min
treatment
group
inhibit
could
incub
pv
min
therefor
time
need
act
pv
short
activ
peak
time
point
min
accord
result
concentr
mgml
nearbi
ec
valu
min
treatment
chosen
assay
peptid
pv
activ
follow
experi
inhibitori
effect
select
pv
distinguish
select
antivir
activ
nonselect
cytotox
test
cytotox
peptid
tzmbl
cell
tzmbl
cell
treat
sever
concentr
peptid
hour
viabil
tzmbl
cell
measur
use
mt
assay
absorb
measur
nm
use
elisa
plate
reader
cc
valu
calcul
spss
shown
tabl
cc
tzmbl
cell
mgml
time
ec
valu
therefor
antivir
activ
peptid
result
cytotox
peptid
tzmbl
cell
order
gain
insight
mechan
activ
interact
time
order
among
pv
cell
vari
four
differ
way
describ
materi
method
prepar
manner
set
mock
group
shown
fig
incub
pv
h
inocul
cell
peptideviru
preincub
group
show
promin
inhibitori
effect
agre
result
although
low
degre
pv
ad
cell
simultan
without
preincub
peptideviru
mixtur
group
also
show
signific
inhibit
howev
neither
peptid
pretreat
group
tzmbl
cell
pretreat
h
infect
first
group
tzmbl
cell
infect
pv
first
treat
show
antivir
effect
fig
base
result
four
treatment
mode
assum
antihiv
activ
attribut
interact
viral
particl
directli
confirm
hypothesi
bind
assay
base
biolay
interferometri
perform
studi
interact
pv
pv
load
ap
biosensor
sensor
tip
transfer
concentr
mgml
mgml
expectedli
observ
rapid
direct
bind
pv
bind
capac
mgml
stronger
mgml
show
signific
bind
pv
fig
therefor
peptid
execut
activ
direct
target
particl
broadspectrum
antivir
activ
pv
defin
whether
antivir
effect
peptid
pv
broadspectrum
mgml
mgml
standard
refer
panel
subtyp
b
isol
measur
use
tzmbl
detect
system
use
neg
control
inhibit
calcul
compar
pv
control
group
mgml
mgml
peptid
show
compar
antivir
potenc
strain
subtyp
b
pv
includ
pvo
tro
neg
control
show
inhibitori
effect
correspond
concentr
mgml
data
shown
fig
consequ
peptid
broadspectrum
antivir
activ
pv
regardless
tropism
confirm
potent
inhibit
replicationcompet
viru
also
adopt
antihiv
activ
assay
serial
dilut
incub
ml
provir
dna
deriv
viru
ng
h
infect
cell
day
supernat
cell
sampl
collect
day
antigen
express
analyz
elisa
infect
detect
tzmbl
detect
system
mgml
mgml
suppress
express
complet
th
day
th
day
infect
cell
fig
well
supernat
fig
mgml
suppress
express
cell
sampl
earli
stage
th
day
th
day
later
time
point
valu
rose
th
day
till
th
day
fig
antigen
level
supernat
show
trend
cell
sampl
mgml
delay
reaction
fig
neg
control
peptid
show
inhibitori
effect
determin
antivir
activ
sampl
ad
tzmbl
cell
detect
infect
luciferas
activ
infect
tzmbl
cell
measur
h
incub
similar
trend
inhibitori
effect
observ
fig
howev
mgml
inhibit
viru
replic
complet
mgml
fig
mgml
show
complet
suppress
assay
fig
result
demonstr
inhibit
hiv
infect
consequ
replic
rule
potenti
inhibit
attribut
cytotox
host
cell
cytotox
peptid
cell
measur
use
mt
assay
mgml
mgml
cc
valu
cell
mgml
shown
antivir
activ
result
cytotox
peptid
cell
brief
scorpion
venom
peptid
deriv
significantli
inhibit
pv
also
antivir
effect
replicationcompet
viru
broadspectrum
direct
interact
viral
particl
may
becom
promis
candid
compound
develop
agent
three
decad
hivaid
wreak
havoc
popul
world
although
number
new
infect
fall
level
new
infect
overal
still
high
vast
major
peopl
newli
infect
hiv
infect
unprotect
sexual
intercours
quest
effect
microbicid
drug
prevent
initi
infect
treat
aid
patient
essenti
counter
spread
diseas
worldwid
effect
prophylact
hiv
vaccin
avail
present
tremend
effort
direct
toward
develop
effect
microbicid
defin
product
appli
topic
prevent
sexual
transmit
infect
creat
chemic
biolog
andor
physic
barrier
effect
microbicid
hiv
effici
activ
safe
low
cytotox
host
cell
broadspectrum
satisfi
criteria
resourc
possibl
reagent
explor
previou
studi
isol
sever
kind
cation
antimicrobi
peptid
cdna
librari
venom
gland
scorpion
identifi
antibacteri
activ
pathogen
recent
report
one
kind
modifi
scorpion
venom
peptid
inhibit
rna
virus
measl
viru
sarscov
influenza
virus
studi
screen
efficaci
five
scorpion
venom
peptid
deriv
result
show
exhibit
vari
degre
antivir
effect
among
peptid
effect
ec
valu
mgml
fig
accord
potent
activ
low
toxic
tzmbl
cell
mous
skin
model
unpublish
data
chosen
investig
clarifi
effect
modifi
enhanc
net
posit
charg
hydrophil
side
amphiphil
helix
amino
acid
replac
found
higher
activ
similar
cc
cell
even
decreas
toxic
respons
mous
skin
model
test
unpublish
data
modif
improv
specif
antivir
activ
certain
extend
howev
mechan
need
studi
sinc
major
coreceptor
involv
sexual
transmiss
becom
lead
infect
rout
antivir
activ
import
therefor
pv
toler
pv
monoclon
antibodi
standard
refer
panel
subtyp
b
pseudotyp
viru
chosen
test
antivir
activ
show
potent
antivir
activ
doseand
timedepend
manner
fig
studi
demonstr
effect
subtyp
b
pv
regardless
tropism
select
index
si
also
highli
effect
suppress
replicationcompet
strain
fig
result
demonstr
broadspectrum
accord
previou
find
scorpion
venom
peptid
broadspectrum
biocid
hand
proven
activ
cellfre
cellassoci
replicationcompet
exhibit
suppress
capabl
infect
tzmbl
cell
mgml
almost
complet
inhibit
viral
replic
fig
shown
cole
et
al
evolv
littl
resist
continu
passag
presenc
defensin
anoth
kind
cation
antimicrobi
peptid
may
also
possess
particular
properti
reduc
likelihood
emerg
resist
subsequ
spread
infect
report
earlier
scorpion
venom
peptid
display
antipathogen
activ
break
bacteria
directli
assum
may
implement
inhibit
similar
mechan
experi
four
differ
treatment
group
pv
viral
infect
inhibit
chanc
interact
directli
pv
gave
us
hint
may
exert
antivir
activ
damag
hiv
viru
particl
clarifi
presumpt
tri
bind
assay
possibl
interact
pv
octet
red
system
use
ap
sensor
result
confirm
could
directli
bind
howev
whether
viral
particl
could
broken
bind
clear
experi
effect
action
time
pv
observ
min
interact
allow
show
almost
maximum
inhibit
pv
fig
told
us
activ
rapid
direct
similar
action
manner
mucroporin
bacteria
barrelstav
model
might
explain
happen
viru
extent
may
deduc
action
principl
follow
encount
bind
envelop
directli
immedi
attach
aggreg
insert
viral
envelop
hydrophob
peptid
region
align
lipid
core
region
hydrophil
peptid
region
form
interior
region
pore
help
posit
charg
peptid
somehow
howev
investig
need
done
clarif
epidem
combin
lack
effect
vaccin
urg
us
find
new
resourc
antivir
agent
help
control
transmiss
studi
ration
design
peptid
show
potent
antivir
activ
strain
subtyp
b
strain
direct
interact
viru
regardless
tropism
low
cytotox
data
present
suggest
potenti
microbicid
candid
viru
even
becom
power
drug
compon
conjug
specif
antibodi
scorpion
venom
peptid
least
serv
molecular
templat
design
antivir
peptid
pharmacokinet
pharmacodynam
toxicolog
studi
anim
model
worth
conduct
defin
safeti
paramet
applic
potenti
practic
use
prevent
agent
transmiss
amino
acid
antimicrobi
peptid
clone
venom
mesobuthu
martensii
karsch
optim
design
substitut
glycin
alanin
serin
lysin
arginin
mucroporin
amino
acid
peptid
venom
scorpion
lycha
mucronatu
deriv
mucroporin
substitut
glycin
prolin
residu
lysin
arginin
peptid
remov
ntermin
amino
acid
mucroporin
control
studi
fikriarllrkif
figaiarllskif
mucroporin
lfglipsligglvsafk
lfrlikslikrlvsafk
sligglvsafk
synthes
abim
am
synthes
fmoc
solidphas
peptid
synthesi
purif
character
carri
describ
briefli
peptid
purifi
column
elit
hplc
china
use
linear
gradient
peak
detect
absorb
nm
collect
manual
thereaft
peptid
lyophil
puriti
test
highperform
liquid
chromatographi
hplc
mass
spectrometri
program
divis
aid
niaid
nation
institut
health
genet
engin
hela
cell
clone
express
engin
vector
contain
tatrespons
report
gene
firefli
luciferas
luc
contribut
john
kapp
xiaoyun
wu
vero
cell
line
obtain
american
type
cultur
collect
rockvil
md
us
tzmbl
vero
cell
cultur
dulbecco
modifi
eagl
medium
gibco
dmem
contain
fetal
bovin
serum
fb
heatinactiv
gibco
lglutamin
penicillinstreptomycin
gibco
cell
incub
humidifi
atmospher
contain
co
cell
cultur
rpmi
medium
gibco
supplement
fb
lglutamin
penicillinstreptomycin
clone
pseudotyp
virusbas
assay
provid
nih
aid
research
refer
reagent
program
stock
envpseudotyp
viru
produc
cell
briefli
follow
cell
cellsml
cotransfect
mg
envdefici
backbon
vector
mg
plasmid
encod
envelop
protein
one
strain
subtyp
b
pvo
tro
use
agent
invitrogen
plate
pvcontain
cultur
supernat
harvest
h
transfect
centrifug
purifi
mm
filter
store
ml
aliquot
tissu
cultur
infecti
dose
tcid
measur
done
triplic
use
serial
fourfold
dilut
pv
dilut
everi
well
cultur
plate
ad
ml
dilut
pv
firstli
trypsin
tzmbl
cell
cell
ml
growth
medium
contain
mgml
deaedextran
sigma
plate
incub
humidifi
co
atmospher
h
measur
luciferas
activ
cultur
medium
remov
monolay
wash
ml
pb
ml
cell
cultur
lysi
buffer
promega
ad
cell
incub
min
room
temperatur
allow
cell
lysi
ml
cell
lysat
transfer
black
solid
plate
promega
rel
luminesc
unit
rlu
activ
measur
luciferas
assay
system
accord
manufactur
instruct
promega
use
tuner
biosystem
modulu
ii
sampl
produc
rel
light
unit
rlu
well
contain
cell
score
posit
infect
endpoint
viru
titer
tcid
calcul
spearmankarb
method
except
broadspectrum
antivir
effect
assay
panel
pv
pvo
tro
pv
use
hiv
isol
use
pseudotyp
virusrel
experi
subtyp
b
provir
dna
molecular
clone
use
produc
replicationcompet
viru
transfect
vero
cell
agent
viru
propag
cell
cultur
maintain
hivcontain
cell
supernat
collect
replicationcompet
virus
quantifi
concentr
vitro
cytotox
test
perform
mt
procedur
briefli
tzmbl
cell
seed
plate
densiti
cellswel
triplic
incub
h
thereaft
cultur
medium
replac
ml
serial
dilut
peptid
mgml
mgml
dmem
cultur
cell
incub
anoth
h
dilut
test
triplic
experi
repeat
three
time
ml
celltit
aqueou
one
solut
reagent
promega
ad
well
assay
plate
contain
ml
sampl
cultur
medium
plate
incub
h
humidifi
co
atmospher
absorb
measur
nm
use
elisa
plate
reader
multiskan
thermo
labsystem
rel
cell
viabil
relat
control
well
contain
cell
cultur
medium
without
peptid
calcul
test
cytotox
peptid
express
cytotox
concentr
cc
concentr
inhibit
growth
cell
rel
nontreat
control
cell
test
antivir
effect
peptid
pseudotyp
virusbas
assay
tzmbl
system
perform
describ
previous
briefli
tcid
pv
incub
indic
concentr
test
scorpion
venom
peptid
total
volum
ml
min
indic
time
interv
consid
timecours
effect
triplic
plate
incub
freshli
trypsin
tzmbl
cell
cell
ml
growth
medium
contain
mgml
deaedextran
ad
well
incub
h
luciferas
activ
tzmbl
cell
measur
antivir
activ
test
peptid
viru
control
blank
control
set
well
cell
plu
viru
cell
respect
screen
assay
antiviru
effect
mgml
peptid
use
follow
pv
effect
assay
mgml
lead
peptid
truncat
control
peptid
use
except
dosedepend
effect
experi
serial
dilut
mgml
mg
ml
use
timedepend
effect
experi
mgml
peptid
incub
tcid
pv
min
min
min
min
min
respect
three
dilut
peptid
mgml
mgml
mgml
incub
replicationcompet
viru
ng
h
thereaft
compound
ad
cell
cellsml
duplic
plate
sampl
collect
day
infect
supernat
cell
sampl
separ
centrifug
rpm
min
thermo
sampl
detect
elisa
measur
infect
tzmbl
detect
system
describ
order
help
determin
possibl
antivir
mechan
peptid
four
differ
treatment
group
design
comparison
antivir
effect
follow
peptid
pretreat
group
tzmbl
cell
pretreat
mgml
peptid
h
treat
pv
infect
first
group
tzmbl
cell
infect
pv
first
inocul
h
treat
mg
ml
peptid
peptideviru
mixtur
group
tzmbl
cell
treat
mixtur
pv
mgml
peptid
immedi
mix
without
inocul
peptid
viru
preincub
group
tzmbl
cell
infect
mixtur
pv
mgml
peptid
preincub
h
compar
effect
peptid
viral
infect
tzmbl
cell
measur
luciferas
activ
assay
h
incub
describ
tcid
pv
use
differ
treatment
group
parallel
control
group
set
four
manner
protein
detect
elisa
protein
detect
doubl
antibodi
sandwich
elisa
use
briefli
elisa
plate
greiner
bioon
micropl
coat
rabbit
polycloneantibodi
mgml
carbon
buffer
nahco
na
co
ph
h
thereaft
plate
block
use
fb
pb
overnight
sampl
serial
dilut
pb
contain
fb
vv
treat
h
releas
pv
particl
standard
sampl
treat
way
creat
standard
curv
treat
sampl
dilut
place
well
h
plate
wash
time
pb
contain
tween
pbst
mous
antibodi
ad
incub
h
wash
time
pbst
ml
tmb
sigma
aldrich
ad
well
incub
minut
room
temperatur
depend
degre
colorimetr
convers
standard
sampl
reaction
stop
h
plate
read
nm
nm
od
valu
od
valu
nm
od
valu
nm
standard
curv
drawn
linear
regress
equat
made
linear
rang
pgml
pgml
concentr
sampl
comput
use
equat
bind
assay
perform
micropl
octet
red
system
ferbio
measur
process
comput
control
run
carri
place
ap
sensor
well
measur
chang
layer
thick
nanomet
nm
time
serial
dilut
peptid
run
ml
volum
assay
firstli
ap
sensor
rins
dmem
buffer
serv
background
buffer
secondli
ap
sensor
coupl
ml
cultur
contain
pv
thirdli
ap
sensor
move
dmem
buffer
incub
anoth
clear
unabsorb
pv
lastli
ap
sensor
expos
concentr
mgml
mgml
associ
monitor
follow
dissoci
dmem
buffer
alon
anoth
standard
curv
measur
begin
end
assay
confirm
reproduc
valid
time
taken
run
row
sampl
data
process
automat
use
octet
user
softwar
version
viru
titer
calcul
within
individu
experi
use
method
reed
muench
statist
analys
conduct
use
graphpad
prism
version
statist
comparison
conduct
use
unpair
test
p
valu
consid
signific
data
present
one
repres
least
three
repeat
experi
express
mean
standard
deviat
sd
triplic
valu
tcid
cc
ec
analog
comput
spss
statist
softwar
version
spss
chicago
il
